Adage Capital Partners Gp, L.L.C. Bio Xcel Therapeutics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$2.32 - $5.51 $615,683 - $1.46 Million	265,381 Added 132.69%	465,381 $1.37 Million
Q3 2023 Nov 14, 2023	SELL	$2.49 - $11.85 $4.36 Million - $20.8 Million	-1,752,500 Reduced 89.76%	200,000 $505,000
Q2 2023 Aug 14, 2023	SELL	$6.39 - $28.58 $827,370 - $3.7 Million	-129,479 Reduced 6.22%	1,952,500 $13 Million
Q1 2023 May 15, 2023	BUY	$17.7 - $33.24 $21.4 Million - $40.1 Million	1,206,979 Added 137.94%	2,081,979 $38.8 Million
Q4 2022 Feb 14, 2023	BUY	$10.25 - $22.43 $8.97 Million - $19.6 Million	875,000 New	875,000 $18.8 Million

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $14.3M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.